
Adora offers clinically-led menopause management support, combining women's health experts with personalized digital solutions to improve outcomes for employees. The platform aims to empower women by providing accessible, evidence-based information and fostering a supportive community. It helps employers reduce the impact of menopause on retention and productivity, improve gender equity, and support senior workers. Key features include symptom tracking, one-to-one appointments with specialists, access to expert-led content, webinars, and a community space. Adora also provides education and training for workplaces to create a more supportive environment. The company is a Class 1 Medical device and MHRA registered, adhering to high safety and quality standards.

Adora offers clinically-led menopause management support, combining women's health experts with personalized digital solutions to improve outcomes for employees. The platform aims to empower women by providing accessible, evidence-based information and fostering a supportive community. It helps employers reduce the impact of menopause on retention and productivity, improve gender equity, and support senior workers. Key features include symptom tracking, one-to-one appointments with specialists, access to expert-led content, webinars, and a community space. Adora also provides education and training for workplaces to create a more supportive environment. The company is a Class 1 Medical device and MHRA registered, adhering to high safety and quality standards.
Product: Clinically-led perimenopause and menopause digital app plus employer workplace support (symptom tracking, 1:1 specialist appointments, content, webinars, community).
Regulatory: MHRA registered as a Class I medical device with UKCA marking.
Founders: Ann O'Neill (Co-Founder & CEO), Ed Smith (Co-founder & CTO), Dr Karen Morton (co-founder; NHS consultant gynaecologist).
Funding: Seed round announced 2023-06-22; lead investors listed as Alumni Ventures and Nina Capital (amount not disclosed).
Team size: 19 employees
Perimenopause and menopause care and workplace menopause support.
Digital health
Reported investors also include Angel Academe and Cambridge Angels group; number of investors listed as four in some databases; amount not publicly disclosed in available sources.
“Backed by early-stage investors including Alumni Ventures and Nina Capital, with participation from angel/angel-group investors (Angel Academe, Cambridge Angels).”